Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Healthequity (HQY) over the last 12 years, with Q4 2025 value amounting to $111.2 million.

  • Healthequity's Receivables - Net rose 424.6% to $111.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $111.2 million, marking a year-over-year increase of 424.6%. This contributed to the annual value of $118.0 million for FY2025, which is 1250.13% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's Receivables - Net is $111.2 million, which was up 424.6% from $111.2 million recorded in Q3 2025.
  • Healthequity's 5-year Receivables - Net high stood at $118.0 million for Q1 2025, and its period low was $72.8 million during Q1 2021.
  • Its 5-year average for Receivables - Net is $96.2 million, with a median of $96.5 million in 2023.
  • Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 3078.5% in 2021, then soared by 238.32% in 2023.
  • Over the past 5 years, Healthequity's Receivables - Net (Quarter) stood at $84.1 million in 2021, then grew by 4.32% to $87.7 million in 2022, then grew by 9.65% to $96.2 million in 2023, then increased by 10.95% to $106.7 million in 2024, then grew by 4.25% to $111.2 million in 2025.
  • Its Receivables - Net stands at $111.2 million for Q4 2025, versus $111.2 million for Q3 2025 and $116.3 million for Q2 2025.